Cardiovascular risk models

Editorial

Luc Bonneux. BMJ. 2007.

. 2007 Jul 21;335(7611):107-8.

doi: 10.1136/bmj.39262.643090.47. Epub 2007 Jul 6.

Abstract

The moral implications of models based on absolute risk need to be better understood

Competing interests: None declared.

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Hippisley-Cox J, et al. BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5. BMJ. 2007. PMID: 17615182 Free PMC article.

1. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK. A new cardiovascular disease risk score for the UK. BMJ 2007. doi: - DOI - PMC - PubMed
1. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346:1467-71. - PubMed
1. Essink-Bot ML, Kruijshaar ME, Barendregt JJ, Bonneux LG. Evidence-based guidelines, time-based health outcomes, and the Matthew effect. Eur J Public Health 2007;17:314-7. - PubMed
1. Flesch M, Rosenkranz S, Erdmann E, Bohm M. Alcohol and the risk of myocardial infarction. Basic Res Cardiol 2001;96:128-35. - PubMed
1. Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, Mackenbach JP. The polymeal: a more natural, safer, and probably tastier (than the polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 2004;329:1447-50. - PMC - PubMed